Skip to main content

Articles

Page 87 of 107

  1. Extensive mammographic density in women is associated with increased risk for breast cancer. Mouse models provide a powerful approach to the study of human diseases, but there is currently no model that is sui...

    Authors: Mehrdad Hariri, Geoffrey A Wood, Marco A DiGrappa, Michelle MacPherson, Stephanie A Backman, Martin J Yaffe, Tak W Mak, Norman F Boyd and Rama Khokha
    Citation: Breast Cancer Research 2004 6:R540
  2. Cyclin E, a G1 cyclin essential for G1–S phase transition, is known to have a profound effect on tumorigenesis. Elevated levels of cyclin E have been associated with breast cancer, and chromosomal instability obs...

    Authors: Nicole E Willmarth, Donna G Albertson and Stephen P Ethier
    Citation: Breast Cancer Research 2004 6:R531
  3. This report describes the isolation and characterization of three new murine mammary epithelial cell lines derived from mammary tumors from MMTV (mouse mammary tumor virus)/activated Neu + TβRII-AS (transformi...

    Authors: Anne EG Lenferink, Joanne Magoon, Christiane Cantin and Maureen D O'Connor-McCourt
    Citation: Breast Cancer Research 2004 6:R514
  4. Genomic and transcriptomic alterations affecting key cellular processes such us cell proliferation, differentiation and genomic stability are considered crucial for the development and progression of cancer. M...

    Authors: Martin C Abba, Jeffrey A Drake, Kathleen A Hawkins, Yuhui Hu, Hongxia Sun, Cintia Notcovich, Sally Gaddis, Aysegul Sahin, Keith Baggerly and C Marcelo Aldaz
    Citation: Breast Cancer Research 2004 6:R499

    The Erratum to this article has been published in Breast Cancer Research 2004 7:32

  5. UDP-glucuronosyltransferase (UGT) and sulfotransferase (SULT) enzymes are involved in removing sex hormones from circulation. Polymorphic variation in five UGT and SULT genes – UGT1A1 ((TA)6/(TA)7), UGT2B4 (Asp45...

    Authors: Rachel Sparks, Cornelia M Ulrich, Jeannette Bigler, Shelley S Tworoger, Yutaka Yasui, Kumar B Rajan, Peggy Porter, Frank Z Stanczyk, Rachel Ballard-Barbash, Xiaopu Yuan, Ming Gang Lin, Lynda McVarish, Erin J Aiello and Anne McTiernan
    Citation: Breast Cancer Research 2004 6:R488
  6. Activated leukocyte cell adhesion molecule (ALCAM) (CD166) is an immunoglobulin molecule that has been implicated in cell migration. The present study examined the expression of ALCAM in human breast cancer an...

    Authors: Judy A King, Solomon F Ofori-Acquah, Troy Stevens, Abu-Bakr Al-Mehdi, Oystein Fodstad and Wen G Jiang
    Citation: Breast Cancer Research 2004 6:R478
  7. Lymph node status is one of the decisive prognostic factors in breast cancer. Chemotherapy targeting regional lymphatic tissues has emerged as a promising therapy for the treatment of malignancies with a high ...

    Authors: Jianghao Chen, Ling Wang, Qing Yao, Rui Ling, Kaizong Li and Hui Wang
    Citation: Breast Cancer Research 2004 6:R474
  8. The role of specific dietary factors in breast cancer causation is not completely resolved. Results from prospective studies do not support the concept that fat intake in middle life has a major relation to br...

    Authors: Michelle D Holmes and Walter C Willett
    Citation: Breast Cancer Research 2004 6:170
  9. The present clinical trial update consists of a review of two of eight current studies (the 10981-22023 AMAROS trial and the 10994 p53 trial) of the European Organization for Research and Treatment of Cancer B...

    Authors: Emiel JT Rutgers, Philip Meijnen and Hervé Bonnefoi
    Citation: Breast Cancer Research 2004 6:165
  10. Previous epidemiologic studies suggest that women with variant cytochrome P4501A1 (CYP1A1) genotypes who smoke cigarettes are at increased risk for breast cancer.

    Authors: Yu Li, Robert C Millikan, Douglas A Bell, Lisa Cui, Chiu-Kit J Tse, Beth Newman and Kathleen Conway
    Citation: Breast Cancer Research 2004 6:R460
  11. The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key regulator of the cellular response to hypoxia. Previous studies showed that concentrations of its subunit HIF-1α, as a surrogate for HIF-1 a...

    Authors: Reinhard Bos, Paul J van Diest, Petra van der Groep, Avi Shvarts, Astrid E Greijer and Elsken van der Wall
    Citation: Breast Cancer Research 2004 6:R450
  12. Oestrogen receptor α, which mediates the effect of oestrogen in target tissues, is genetically polymorphic. Because breast cancer development is dependent on oestrogenic influence, we have investigated whether...

    Authors: Sara Wedrén, Lovisa Lovmar, Keith Humphreys, Cecilia Magnusson, Håkan Melhus, Ann-Christine Syvänen, Andreas Kindmark, Ulf Landegren, Maria Lagerström Fermér, Fredrik Stiger, Ingemar Persson, John Baron and Elisabete Weiderpass
    Citation: Breast Cancer Research 2004 6:R437
  13. Pregnancy protects against breast cancer development in humans and rats. Parous rats have persistently reduced circulating levels of growth hormone, which may affect the activity of the growth hormone/insulin-...

    Authors: Gudmundur Thordarson, Nicole Slusher, Harriet Leong, Dafne Ochoa, Lakshmanaswamy Rajkumar, Raphael Guzman, Satyabrata Nandi and Frank Talamantes
    Citation: Breast Cancer Research 2004 6:R423
  14. The ataxia telangiectasia mutated (ATM) gene is a tumor suppressor gene with functions in cell cycle arrest, apoptosis, and repair of DNA double-strand breaks. Based on family studies, women heterozygous for muta...

    Authors: Rulla M Tamimi, Susan E Hankinson, Donna Spiegelman, Peter Kraft, Graham A Colditz and David J Hunter
    Citation: Breast Cancer Research 2004 6:R416
  15. Sentinel lymph node (SLN) biopsy allows identification of the first lymph node into which a primary tumor drains. In breast cancer, identification of tumor cells in the SLNs is a predictor of the tumor's metas...

    Authors: Nancy J Poindexter, Aysegul Sahin, Kelly K Hunt and Elizabeth A Grimm
    Citation: Breast Cancer Research 2004 6:R408
  16. The S100 gene family comprises more than 20 members whose protein sequences encompass at least one EF-hand Ca2+ binding motif. The expression of individual family members is not ubiquitous for all tissues and the...

    Authors: Ethan D Emberley, Leigh C Murphy and Peter H Watson
    Citation: Breast Cancer Research 2004 6:153
  17. Germline mutations in the genes BRCA1 and BRCA2 account for only a proportion of hereditary breast cancer, suggesting that additional genes contribute to hereditary breast cancer. Recently a heterozygous variant ...

    Authors: Geoffrey J Lindeman, Melody Hiew, Jane E Visvader, Jennifer Leary, Michael Field, Clara L Gaff, RJ McKinlay Gardner, Kevin Trainor, Glenice Cheetham, Graeme Suthers and Judy Kirk
    Citation: Breast Cancer Research 2004 6:R401
  18. Genetic polymorphisms in the promoter region of the tumour necrosis factor (TNF) gene can regulate gene expression and have been associated with inflammatory and malignant conditions. We have investigated two ...

    Authors: Iman AF Azmy, Saba P Balasubramanian, Anthony G Wilson, Timothy J Stephenson, Angela Cox, Nicola J Brown and Malcolm WR Reed
    Citation: Breast Cancer Research 2004 6:R395
  19. Gene promoter methylation is an important regulator of expression and is a key epigenetic factor in tumorigenesis. DNA methylation is mediated by DNA methyltransferases (DNMTs), of which three active forms hav...

    Authors: Karen G Montgomery, Mira CP Liu, Diana M Eccles and Ian G Campbell
    Citation: Breast Cancer Research 2004 6:R390
  20. The etiology of familial breast cancer is complex and involves genetic and environmental factors such as hormonal and lifestyle factors. Understanding familial aggregation is a key to understanding the causes ...

    Authors: Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd, Saundra S Buys, Mary B Daly, Frances P O'Malley, Regina M Santella, Melissa C Southey, Vickie L Venne…
    Citation: Breast Cancer Research 2004 6:R375
  21. We suggest that surgical extirpation of primary breast cancer among other effects accelerates relapse for some premenopausal node-positive patients. These accelerated relapses occur within 10 months of surgery...

    Authors: Michael Retsky, Gianni Bonadonna, Romano Demicheli, Judah Folkman, William Hrushesky and Pinuccia Valagussa
    Citation: Breast Cancer Research 2004 6:R372
  22. Mutations in BRCA1, BRCA2, ATM, TP53, CHK2 and PTEN account for many, but not all, multiple-case breast and ovarian cancer families. The histone acetyltransferase gene EP300 may function as a tumour suppressor ge...

    Authors: Ian G Campbell, David Choong and Georgia Chenevix-Trench
    Citation: Breast Cancer Research 2004 6:R366
  23. Breast cancer risk may be determined by various genetic, metabolic, and lifestyle factors that alter sex hormone metabolism. Cytochrome P450 1A2 (CYP1A2) is responsible for the metabolism of estrogens and many...

    Authors: Chi-Chen Hong, Bing-Kou Tang, Geoffrey L Hammond, David Tritchler, Martin Yaffe and Norman F Boyd
    Citation: Breast Cancer Research 2004 6:R352
  24. Mammographically dense breast tissue is a strong predictor of breast cancer risk, and is influenced by both mitogens and mutagens. One enzyme that is able to affect both the mitogenic and mutagenic characteris...

    Authors: Chi-Chen Hong, Bing-Kou Tang, Venketeshwer Rao, Sanjiv Agarwal, Lisa Martin, David Tritchler, Martin Yaffe and Norman F Boyd
    Citation: Breast Cancer Research 2004 6:R338
  25. Compromised patterns of gene expression result in genomic instability, altered patterns of gene expression and tumour formation. Specifically, aberrant DNA hypermethylation in gene promoter regions leads to ge...

    Authors: Bekim Sadikovic, Thomas R Haines, Darci T Butcher and David I Rodenhiser
    Citation: Breast Cancer Research 2004 6:R329
  26. Early clinical trials, mostly in the setting of melanoma, have shown that dendritic cells (DCs) expressing tumor antigens induce some immune responses and some clinical responses. A major difficulty is the ext...

    Authors: Eve-Marie Neidhardt-Berard, Frederic Berard, Jacques Banchereau and A Karolina Palucka
    Citation: Breast Cancer Research 2004 6:R322
  27. The present study was conducted to examine the effect of conjugated docosahexaenoic acid (CDHA) on cell growth, cell cycle progression, mode of cell death, and expression of cell cycle regulatory and/or apopto...

    Authors: Miki Tsujita-Kyutoku, Takashi Yuri, Naoyuki Danbara, Hideto Senzaki, Yasuhiko Kiyozuka, Norihisa Uehara, Hideho Takada, Takahiko Hada, Teruo Miyazawa, Yutaka Ogawa and Airo Tsubura
    Citation: Breast Cancer Research 2004 6:R291

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions